Arsenic: Toxicity, oxidative stress and human disease

Journal of Applied Toxicology

Volumn 31, Issue 2, 2011, Pages 95-107

  Jomova, K ^a   Jenisova, Z ^a   Feszterova, M ^a   Baros, S ^a   Liska, J ^b   Hudecova, D ^c   Rhodes, C J ^d   Valko, M ^c  

^a The Philosopher University in Nitra Geoinformatics and Regional Development   (Slovakia)

^b Physics and Informatics   (Slovakia)

^c SLOVAK UNIVERSITY OF TECHNOLOGY   (Slovakia)

^d Fresh lands Environmental Actions   (United Kingdom)

Author keywords

Antioxidants; Arsenic; Free radicals; Human disease; Oxidative stress; RNS; ROS

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ARSENIC; ARSENIC ACID; ARSENIC TRIOXIDE; ARSENOBETAINE; ASCORBIC ACID; BILIRUBIN; BIOLOGICAL MARKER; CACODYLIC ACID; CARCINOGEN; CATALASE; CURCUMIN; DRINKING WATER; GALLIUM ARSENIDE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; METHANEARSONIC ACID; SUPEROXIDE DISMUTASE; UROPORPHYRIN;

ABDOMINAL PAIN; ANTIOXIDANT ACTIVITY; ARSENIC POISONING; ARSENIC TOXICITY; ATHEROSCLEROSIS; CANCER RISK; CARCINOGENESIS; CARDIOVASCULAR EFFECT; CONTACT DERMATITIS; COPROPORPHYRIA; DIARRHEA; DNA SYNTHESIS; ENVIRONMENTAL EXPOSURE; ENZYME DEGRADATION; FOOD CONTAMINATION; GASTROINTESTINAL SYMPTOM; GENOTOXICITY; HEALTH HAZARD; HEME SYNTHESIS; HERBAL MEDICINE; HUMAN; HYPERKERATOSIS; HYPERPIGMENTATION; HYPERTENSION; KERATINOCYTE; KIDNEY DISEASE; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER INJURY; LONG TERM EXPOSURE; LUNG CANCER; MALIGNANT TRANSFORMATION; METABOLISM; NAUSEA; NEOPLASM; NEUROLOGIC DISEASE; NITROSATIVE STRESS; OXIDATIVE STRESS; POLLUTANT; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; REVIEW; SKIN CANCER; SKIN DISEASE; SKIN IRRITATION; SMOKING; SOIL POLLUTION; STOMACH CANCER; TOXICITY; URINARY EXCRETION; URINE LEVEL; VOMITING; WATER CONTAMINATION;

ANIMALS; ARSENIC; ARSENIC POISONING; ARSENICALS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; ENVIRONMENTAL POLLUTANTS; HUMANS; MUTAGENS; NEOPLASMS; OXIDATIVE STRESS; POISONS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

ANIMALIA;

EID: 79951965233     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1649     Document Type: Review

References (139)

1. Ahmad S, Anderson WL, Kitchin KT. 1999. Dimethylarsinic acid effects on DNA damage and oxidative stress related biochemical parameters in B6C3F1 mice. Cancer Lett. 139: 129-135.
2. Albores A, Cebrian ME, Bach PH, Connelly JC, Hinton RH, Bridges JW. 1989. Sodium arsenite induced alterations in bilirubin excretion and heme metabolism. J. Biochem. Toxicol. 4: 73-78.
3. Aposhian HV. 1997. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu. Rev. Pharmacol. Toxicol. 37: 397-419.
4. Aposhian HV, Gurzau ES, Le XC, Gurzau A, Healy SM, Lu X, Ma M, Yip L, Zakharyan RA, Maiorino RM, Dart RC, Tircus MG, Gonzalez-Ramirez D, Morgan DL, Avram D, Aposhian MM. 2000a. Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem. Res. Toxicol. 13: 693-697.
5. Aposhian HV, Zheng B, Aposhian MM, Le XC, Cebrian ME, Cullen W, Zakharyan RA, Ma M, Dart RC, Cheng Z, Andrewes P, Yip L, O'Malley GF, Maiorino RM, Van Voorhies W, Healy SM, Titcomb A. 2000b. DMPS-arsenic challenge test. II. Modulation of arsenic species, including monomethylarsonous acid (MMA(III)), excreted in human urine. Toxicol. Appl. Pharmacol. 165: 74-83.
6. Arnold LL, Eldan M, van Gemert M, Capen CC, Cohen SM. 2003. Chronic studies evaluating the carcinogenicity of monomethylarsonic acid in rats and mice. Toxicology 190: 197-219.
7. Balakumar BS, Suresh R, Venugopal R. 2010. Modulatory effects of ascorbic acid and α-tocopherol on arsenic induced micronuclei formation. Int. J. Pharmacol. 6: 676-680.
8. Balakumar P, Kaur J. 2009. Arsenic exposure and cardiovascular disorders: an overview. Cardiovasc. Toxicol. 9: 169-176.
9. Barchowsky A, Klei LR, Dudek EJ, Swartz HM, James PE. 1999. Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite. Free Radic. Biol. Med. 27: 1405-1412.
10. Bartolome B, Cordoba S, Nieto S, Fernández-Herrera J, García-Díez A. 1999. Acute arsenic poisoning: clinical and histopathological features. Br. J. Dermatol. 141: 1106-1109.
11. Bashir S, Sharma Y, Irshad M, Nag TC, Tiwari M, Kabra M, Dogra TD. 2006. Arsenic induced apoptosis in rat liver following repeated 60days exposure. Toxicology 217: 63-70.
12. Bergquist ER, Fischer RJ, Sugden KD, Martin BD. 2009. Inhibition by methylated organo-arsenicals of the respiratory 2-oxo-acid dehydrogenases. J. Organomet. Chem. 694: 973-980.
13. Bhattacharya R, Chatterjee D, Nath B, Jana J, Jacks G, Vahter M. 2003. High arsenic groundwater: mobilization, metabolism and mitigation - an overview in the Bengal delta plain. Mol. Cell. Biochem. 253: 347-355.
14. Biswas J, Sinha D, Mukherjee S, Roy S, Siddiqi M, Roy, M. 2010. Curcumin protects DNA damage in a chronically arsenic-exposed population of West Bengal. Human Exp. Toxicol. 29: 513-524.
15. Bulbulyan MA, Jourenkova NJ, Boffetta P, Astashevsky SV, Mukeria AF, Zaridze DG. 1996. Mortality in a cohort of Russian fertilizer workers. Scand. J. Work Environ. Health 22: 27-33.
16. Calderon J, Navarro ME, Jimenez-Capdeville ME, Santos-Diaz MA, Golden A, Rodriguez-Leyva I, Borja-Aburto V, Díaz-Barriga F. 2001. Exposure to arsenic and lead an neuropsychological development in Mexican children. Environ. Res. 85: 69-76.
17. Chakraborti D, Mukherjee SC, Saha KC, Chowdhury UK, Rahman MM, Sengupta MK. 2003. Arsenic toxicity from homeopathic treatment. J. Toxicol. Clin. Toxicol. 41: 963-967.
18. Chattopadhyay S, Ghosh S, Debnath J, Ghosh D. 2001. Protection of sodium arsenite-induced ovarian toxicity by coadministration of l-ascorbate (vitamin C) in mature Wistar strain rat. Arch. Environ. Contam. Toxicol. 41: 83-89.
19. Chattopadhyay S, Pal Ghosh S, Ghosh D, Debnath J. 2003. Effect of dietary co-administration of sodium selenite on sodium arsenite-induced ovarian and uterine disorders in mature albino rats. Toxicol. Sci. 75: 412-422.
20. Chen W, Yang J, Chen J, Bruch J. 2006. Exposures to silica mixed dust and cohort mortality study in tin mines: exposure-response analysis and risk assessment of lung cancer. Am. J. Ind. Med. 49: 67-76.
21. Chou S, Harper C, Ingerman L, Llados F, Colman J, Chappell L, Osier M, Odin M, Sage G. 2007. Toxicological Profile for Arsenic. US Department of Health and Human Service, Agency for Toxic Substances and Disease Registry.
22. Chowdhury UK, Biswas BK, Chowdhury TR, Samanta G, Mandal BK, Basu GC, Chanda CR, Lodh D, Saha KC, Mukherjee SK, Roy S, Kabir S, Quamruzzaman Q, Chakraborti D. 2000. Groundwater arenic contamination in Bangladesh and West Bengal, India. Environ. Health Perspect. 108: 393-397.
23. Cohen SM, Yamamoto S, Cano M, Arnold LL. 2001. Urothelial cytotoxicity and regeneration induced by dimethylarsinic acid in rats. Toxicol. Sci. 59: 68-74.
24. Cohen SM, Wanibuchi H, Fukushima S. 2002. Lower urinary tract. In Handbook of Toxicologic Pathology, 2nd edn, Haschek WM, Rousseaux CG, MA Wallig (eds), Vol. 2. Academic Press: San Diego, CA: 337-361.
25. Cohen SM, Arnold LL, Eldan M, Lewis AS, Beck BD. 2006. Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment. Crit. Rev. Toxicol. 36: 99-133.
26. Cullen NM, Wolf LR, St Clair D. 1995. Pediatric arsenic ingestion. Am. J. Emerg. Med. 13: 432-435.
27. Datta S, Talukder G, Sharma A. 1986. Cytotoxic effects of arsenic in dietary oil primed rats. Sci. Cult. 52: 196-198.
28. De Vizcaya-Ruiz A, Barbier O, Ruiz-Ramos R, Cebrian ME. 2009. Biomarkers of oxidative stress and damage in human populations exposed to arsenic. Mutat. Res. 674: 85-92.
29. Díaz-Villaseñor A, Burns AL, Hiriart M, Cebrián ME, Ostrosky-Wegman P. 2007. Arsenic-induced alteration in the expression of genes related to type 2 diabetes mellitus. Toxicol. Appl. Pharmacol. 225: 123-133.
30. Driesback RH, ed. 1980. Arsenic and arsine. In Handbook of Poisoning: Prevention, Diagnosis and Treatment, 11th edn. Lange Medical Publications: Los Altos, CA; 241-245.
31. Engel RR, Smith AH. 1994. Arsenic in drinking water and mortality from vascular disease: An ecologic analysis in 30 counties in the United States. Arch. Environ. Health 49: 418-427.
32. Engström KS, Vahter M, Johansson G, Lindh CH, Teichert F, Singh R, Kippler M, Nermell B, Raqib R, Strömberg U, Broberg K. 2010. Chronic exposure to cadmium and arsenic strongly influences concentrations of 8-oxo-7, 8-dihydro-2'-deoxyguanosine in urine. Free Radic. Biol. Med. 48: 1211-1217.
33. Enterline PE, Day R, Marsh GM. 1995. Cancers related to exposure to arsenic at a copper smelter. Occup. Environ. Med. 52: 28-32.
34. Fincher R, Koerker RM. 1987. Long-term survival in acute arsenic encephalopathy: Follow-up using newer measures of electrophysiologic parameters. Am. J. Med. 82: 549-552.
35. Flora SJS, Tripathi N. 1998. Hepatic and renal metallothionein induction following single oral administration of gallium arsenide in rats. Biochem. Mol. Biol. Interact. 45: 1121-1127.
36. Flora SJS, Kumar P, Kannan GM, Rai GP. 1998. Acute oral gallium arsenide exposure and changes in certain hematological, hepatic, renal and immunological indices at different time intervals in male Wistar rats. Toxicol. Lett. 94: 103-113.
37. Flora SJS, Bhadauria S, Kannan GM, Singh N. 2007. Arsenic induced oxidative stress and the role of antioxidant supplementation during chelation: a review. J. Environ. Biol. 28: 333-347.
38. Flora SJS, Mittal M, Mehta A. 2008. Heavy metal induced oxidative stress and its possible reversal by chelation therapy. Indian J. Med. Res. 128: 501-523.
39. Foy HM, Tarmapai S, Eamchan P, Metdilogkul O. 1992. Chronic arsenic poisoning from well water in a mining area in Thailand. Asia Pac. J. Public Health 6: 150-152.
40. Galanis A, Karapetsas A, Sandaltzopoulos R. 2009. Metal-induced carcinogenesis, oxidative stress and hypoxia signalling. Mutat. Res. 674: 31-35.
41. Garcia F, Ortega A, Domingo JL, Corbella J. 2001. Accumulation of metals in autopsy tissues of subjects living in Tarragona county, Spain. J. Environ. Sci. Health. Part A 36: 1767-1786.
42. García-Vargas GG, Hernández-Zavala A. 1996. Urinary porphyrins and heme biosynthetic enzyme activities measured by HPLC in arsenic toxicity. Biomed. Chromatogr. 10: 278-284.
43. Gebel TW, Suchenwirth RHR, Bolten C, Dunkelberg HH. 1998. Human biomonitoring of arsenic and antimony in case of an elevated geogenic exposure. Environ. Health Perspect. 106: 33-39.
44. Gemert M, Eldan M. 1998. Chronic carcinogenicity assessment of cacodylic acid. In Society for Environmental Geochemistry and Health (SEGH) Third International Conference on Arsenic Exposure and Health Effects, Book of Abstracts, San Diego, CA, 12-15 July; 113.
45. Germolec DR, Yoshida T, Gaido K, Wilmer JL, Simeonova PP, Kayama F, Burleson F, Dong W, Lange RW, Luster MI. 1996. Arsenic induces overexpression of growth factors in human keratinocytes. Toxicol. Appl. Pharmacol. 141: 308-318.
46. Germolec DR, Spalding J, Boorman GA, Wilmer JL, Yoshida T, Simeonova PP, Bruccoleri A, Kayama F, Gaido K, Tennant R, Burleson F, Dong W, Lang RW, Luster MI. 1997. Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors. Mutat. Res. 386: 209-218.
47. Goebel HH, Schmidt PF, Bohl J, Tettenborn B, Krämer G, Gutmann L. 1990. Polyneuropathy due to acute arsenic intoxication: biopsy studies. J. Neuropathol. Exp. Neurol. 49: 137-149.
48. Gur E, Pirak M, Waner T. 1991. Methanearsonic acid oncogenicity study in the mouse. Luxembourg Industries (Pamol) Ltd. Submitted to the US Environmental Protection Agency.
49. Helleday T, Nilsson R, Jenssen D. 2000. Arsenic [111] and heavy metal ions induce intrachromosomal homologous recombination in the hprt gene V79 Chinese hamster cells. Environ. Mol. Mutagen. 35: 114-122.
50. Hewitt DJ, Millner GC, Nye AC, Simmons HF. 1995. Investigation of arsenic exposure from soil at a Superfund site. Environ. Res. 68: 73-81.
51. Heydorn K. 1970. Environmental variation of arsenic levels in human blood determined by neutron activation analysis. Clin. Chim. Acta 28: 349-357.
52. Heywood R, Sortwell RJ. 1979. Arsenic intoxication in the Rhesus monkey. Toxicol. Lett. 3: 137-144.
53. Holson JF, Stump DG, Ulrich CE, Farr CH. 1999. Absence of prenatal developmental toxicity from inhaled arsenic trioxide in rats. Toxicol. Sci. 51: 87-97.
54. Hsu CH, Yang SA, Wang JY, Yu HS, Lin SR. 1999. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan. Br. J. Cancer 80: 1080-1086.
55. Hu CW, Pan CH, Huang YL, Wu MT, Chang LW, Wang CJ, Chao MR. 2006. Effects of arsenic exposure among semiconductor workers: a cautionary note on urinary 8-oxo-7, 8-dihydro-2'-deoxyguanosine. Free Radic. Biol. Med. 40: 1273-1278.
56. Hughes MF. 2002. Arsenic toxicity and potential mechanisms of action. Toxicol. Lett. 133: 1-16.
57. Hughes MF, Kenyon EM. 1998. Dose-dependent effects on the disposition of monomethylarsonic acid and dimethylarsinic acid in the mouse after intravenous administration. J. Toxicol. Environ. Health A 53: 95-112.
58. Jaghabir MTW, Abdelghani AA, Anderson AC. 1989. Histopathological effects of monosodium methanearsonate (MSMA) on New Zealand white rabbits (Oryctalagus cuniculus). Bull. Environ. Contam. Toxicol. 42: 289-293.
59. Järup L, Pershagen G. 1991. Arsenic exposure, smoking, and lung cancer in smelter workers - a case-control study. Am. J. Epidemiol. 134: 545-551.
60. Jones FT. 2007. A broad view of arsenic. Poultry Sci. 86: 2-14.
61. Kannan GM, Tripathi N, Dube SN, Gupta M, Flora SJ. 2001. Toxic effects of arsenic (III) on some hematopoietic and central nervous system variables in rats and guinea pigs. J. Toxicol. Clin. Toxicol. 39: 675-682.
62. Kennedy S, Rice DA, Cush PF. 1986. Neuropathology of experimental 3-nitro-4-hydroxyphenylarsonic acid toxicosis in pigs. Vet. Pathol. 23: 454-461.
63. Kitchin KT. 2001. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol. Appl. Pharmacol. 172: 249-261.
64. Kitchin KT, Ahmad S. 2003. Oxidative stress as a possible mode of action for arsenic carcinogenesis. Toxicol. Lett. 137: 3-13.
65. Kodavanti UP, Hauser R, Christiani DC, Meng ZH, McGee J, Ledbetter A, Richards J, Costa DL. 1998. Pulmonary responses to oil fly ash particles in the rat differ by virtue of their specific soluble metals. Toxicol. Sci. 43: 204-212.
66. Kraus T, Quidenus G, Schaller KH. 2000. Normal values for arsenic and selenium concentrations in human lung tissue. Arch. Environ. Contam. Toxicol. 38: 384-389.
67. Kuroda K, Yoshida K, Yoshimura M, Endo Y, Wanibuchi H, Fukushima S, Endo G. 2004. Microbial metabolite of dimethylarsinic acid is highly toxic and genotoxic. Toxicol. Appl. Pharmacol. 198: 345-353.
68. Lage CR, Nayak A, Kim CH. 2006. Arsenic ecotoxicity and innate immunity. Integr. Comp. Biol. 46: 1040-1054.
69. Lagerkvist BJ, Zetterlund B. 1994. Assessment of exposure to arsenic among smelter workers: a five-year follow-up. Am. J. Ind. Med. 25: 477-488.
70. Lee DC, Roberts JR, Kelly JJ, Fishman SM. 1995. Whole-bowel irrigation as an adjunct in the treatment of radiopaque arsenic. Am. J. Emerg. Med. 13: 244-245.
71. Liu J, Zheng B, Aposhian HV, Zhou Y, Chen ML, Zhang A, Waalkes MP. 2002. Chronic arsenic poisoning from burning high-arsenic containing coal in Guizhou, China. Environ. Health Perspect. 110: 119-122.
72. Liu SX, Athar M, Lippai I, Waldren C, Hei TK. 2001. Induction of oxyradicals by arsenic: implication for mechanism of genotoxicity. Proc. Natl Acad. Sci. USA 98: 1643-1648.
73. Magalhaes MCF. 2002 Arsenic. An environmental problem limited by solubility. Pure Appl. Chem. 74: 1843-1850.
74. Mandal BK, Suzuki KT. 2002. Arsenic round the world: a review. Talanta 58: 201-235.
75. Mandal BK, Ogra Y, Suzuki KT. 2003. Speciation of arsenic in human nail and hair from arsenic-affected area by HPLC-inductively coupled argon plasma mass spectrometry. Toxicol. Appl. Pharmacol. 189: 73-83.
76. Manna P, Sinha M, Sil PC. 2008. Arsenic-induced oxidative myocardial injury: protective role of arjunolic acid. Arch. Toxicol. 82: 137-149.
77. Martena MJ, Van Der Wielen JC, Rietjens IM, Klerx WN, De Groot HN, Konings EJ. 2010. Monitoring of mercury, arsenic, and lead in traditional Asian herbal preparations on the Dutch market and estimation of associated risks. Food Addit. Contam. Part A Chem. Anal. Control Expos. Risk Assess. 27: 190-205.
78. Mathew L, Vale A, Adcock JE. 2010. Arsenical peripheral neuropathy. Pract. Neurol. 10: 34-38.
79. Mazumdar S, Redmond CK, Enterline PE, Marsh GM, Costantino JP, Zhou SY, Patwardhan RN. 1989. Multistage modeling of lung cancer mortality among arsenic-exposed copper-smelter workers. Risk Anal. 9: 551-563.
80. Mazumder DN, Steinmaus C, Bhattacharya P, von Ehrenstein OS, Ghosh N, Gotway M, Sil A, Balmes JR, Haque R, Hira-Smith MM, Smith AH. 2005. Bronchiectasis in persons with skin lesions resulting from arsenic in drinking water. Epidemiology 16: 760-765.
81. McCarty KM, Chen YC, Quamnuzzaman Q, Rahman M, Mahiuddin G, Hsueh YM, Su L, Smith T, Ryan L, Christiani DC. 2007. Arsenic methylation, GSTT1, GSTM1, GSTP1 polymorphisms and skin lesions. Environ. Health Perspect. 115: 341-345.
82. Menzel DB, Rasmussen RE, Lee E, Meacher DM, Said B, Hamadeh H, Vargas M, Greene H, Roth RN. 1998. Human lymphocyte heme oxygenase 1 as a response biomarker to inorganic arsenic. Biochem. Biophys. Res. Commun. 250: 653-656.
83. Milham S, Strong T. 1974. Human arsenic exposure in relation to a copper smelter. Environ. Res. 7: 176-182.
84. Miller WH Jr, Schipper HM, Lee JS, Singer J, Waxman S. 2002. Mechanisms of action of arsenic trioxide. Cancer Res. 62: 3893-3903.
85. Moore MM, Harrington-Brock K, Doerr CL. 1994. Genotoxicity of arsenic and its methylated metabolites. Environ. Geochem. Health 16: 191-198.
86. Morikawa T, Wanibuchi H, Morimura K, Ogawa M, Fukushima S. 2000. Promotion of skin carcinogenesis by dimethylarsinic acid in keratin (K6)/ODC transgenic mice. Jpn J. Cancer Res. 91: 579-581.
87. Mumford JL, Wu K, Xia Y, Kwok R, Yang Z, Foster J, Sanders WE. 2007. Chronic arsenic exposure and cardiac repolarization abnormalities with QT interval prolongation in a population-based study. Environ. Health Perspect. 115: 690-694.
88. Naughton DP, Grootveld M, Blake DR, Guestrin HR, Narajanaswamy R. 1993. An optical hydroxyl radical sensor. Biosens. Bioelectron. 8: 325-329.
89. Navas-Acien A, Sharrett AR, Silbergeld EK, Schwartz BS, Nachman KE, Burke TA, Guallar E. 2005. Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am. J. Epidemiol. 162: 1037-1049.
90. Nepusz T, Petroczi A, Naughton DP. 2009. Food alert patterns for metal contamination analyses in seafoods: longitudinal and geographical perspectives. Environ. Int. 35: 1030-1033.
91. Nordenson I, Beckman G, Beckman L, Nordström S. 1978. Occupational and environmental risks in and around a smelter in northern Sweden: II. Chromosomal aberrations in workers exposed to arsenic. Hereditas 88: 47-50.
92. Nordenson I, Salmonsson S, Brun E, Beckman G. 1979. Chromosome aberrations in psoriatic patients treated with arsenic. Hum. Genet. 48: 1-6.
93. Okada S, Yamanaka K. 1994. Induction of lung-specific DNA damage by methylarsenics via the production of free radials. In Arsenic in the Environment, Nriagu J (ed.). John Wiley: New York.
94. Okina M, Yoshida K, Kuroda K, Wanibuchi H, Fukushima S, Endo G. 2004. Determiniation of trivalent methylated arsenicals in rat urine by liquid chromatography-inductively couple plasma mass spectrometry after solvent extraction. J. Chromatogr. B 799: 209-215.
95. Orloff K, Mistry K, Metcalf S. 2009. Biomonitoring for environmental exposures to arsenic. J. Toxicol. Environ. Health B Crit. Rev. 12: 509-524.
96. Pesch B, Ranft U, Jakubis P, Nieuwenhuijsen MJ, Hergemöller A, Unfried K, Jakubis M, Miskovic P, Keegan T. 2002. Environmental arsenic exposure from a coal-burning power plant as a potential risk factor for nonmelanoma skin carcinoma: Results from a case-control study in the district of Prievidza, Slovakia. Am. J. Epidemiol. 155: 798-809.
97. Petroczi A, Naughton DP. 2009. Mercury, cadmium and lead contamination in seafood: a comparative study to evaluate the usefulness of Target Hazard Quotients. Food Chem. Toxicol. 47: 298-302.
98. Pi J, Diwan BA, Sun Y, Liu J, Qu W, He Y, Styblo M, Waalkes MP. 2008. Arsenic-induced malignant transformation of human keratinocytes: involvement of Nrf2. Free Radic. Biol. Med. 45: 651-658.
99. Polissar L, Lowry-Coble K, Kalman DA, Hughes JP, van Belle G, Covert DS, Burbacher TM, Bolgiano D, Mottet NK. 1990. Pathways of human exposure to arsenic in a community surrounding a copper smelter. Environ. Res. 53: 29-47.
100. Poma K, Degraeve N, Susanne C. 1987. Cytogenetic effects in mice after chronic exposure to arsenic followed by a single dose of ethylmethane sulfonate. Cytologia 52: 445-449.
101. Quatrehomme G, Ricq O, Lapalus P, Jacomet Y, Ollier A. 1992. Acute arsenic intoxication: forensic and toxicologic aspects (an observation). J. Forensic Sci. 37: 1163-1171.
102. Quyyumi AA. 1998. Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am. J. Med. 105: 32S-39S.
103. Raie RM. 1996. Regional variation in As, Cu, Hg, and Se and interaction between them. Ecotoxicol. Environ. Saf. 35: 248-252.
104. Rossman TG. 2003. Mechanism of arsenic carcinogenesis: an integrated approach. Mutat. Res. 533: 37-65.
105. Sainio EL, Jolanki R, Hakala E, Kanerva L. 2000. Metals and arsenic in eye shadows. Contact Dermat. 42: 5-10.
106. Salim EI, Wanibuchi H, Morimura K, Wei M, Mitsuhashi M, Yoshida K, Endo G, Fukushima S. 2003. Carcinogenicity of dimethylarsinic acid inp53 heterozygous knockout and wild-type C57BL/6J mice. Carcinogenesis 24: 335-342.
107. Salnikow K, Zhitkovich A. 2008. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem. Res. Toxicol. 21: 28-44.
108. Sardana MK, Drummond GS, Sassa S, Kappas A. 1981. The potent heme oxygenase inducing action of arsenic in parasiticidal arsenicals. Pharmacology 23: 247-253.
109. Schroeder HA, Mitchener M. 1971. Toxic effects of trace elements on the reproduction of mice and rats. Arch. Environ. Health 23: 102-106.
110. Shi H, Shi X, Liu KJ. 2004. Oxidative mechanism of arsenic toxicity and carcinogenesis. Mol. Cell. Biochem. 255: 67-78.
111. Siewicki TC. 1981. Tissue retention of arsenic in rats fed witch flounder or cacodylic acid. J. Nutr. 111: 602-609.
112. Smedley PL, Kinniburgh DG. 2002. A review of the source, behaviour and distribution of arsenic in natural waters. Appl. Geochem. 17: 517-568.
113. States JC, Srivastava S, Chen Y, Barchowsky A. 2009. Arsenic and cardiovascular disease. Toxicol. Sci. 107: 312-323.
114. Styblo M, Del Razo LM, Vega L, Germolec DR, LeCluyse EL, Hamilton GA, Reed W, Wang C, Cullen WR, Thomas DJ. 2000. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 74: 289-299.
115. Tam GKH, Charbonneau SM, Bryce F, Pomroy C, Sandi E. 1979. Metabolism of inorganic arsenic (74As) in humans following oral ingestion. Toxicol. Appl. Pharmacol. 50: 319-322.
116. Tsai S, Chou H, The H, Chen CM, Chen CJ. 2003. The effects of chronic arsenic exposure from drinking water on the neurobehavioral development in adolescence. Neurotoxicology 24: 747-753.
117. Tseng W. 1977. Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic. Environ. Health Perspect. 19: 109-119.
118. Tsou TC, Yeh SC, Tsai EM, Tsai FY, Chao HR, Chang LW. 2005. Arsenite enhances tumor necrosis factor-induced expression of vascular cell adhesion molecule-1. Toxicol. Appl. Pharmacol. 209: 10-18.
119. Tsuji JS, Van Kerkhove MD, Kaetzel RS, Kaetzel RS, Scrafford CG, Mink PJ, Barraj LM, Crecelius EA, Goodman M. 2005. Evaluation of exposure to arsenic in residential soil. Environ. Health Perspect. 113: 1735-1740.
120. Uede K, Furukawa F. 2003. Skin manifestations in acute arsenic poisoning from the Wakayama curry-poisoning incident. Br. J. Dermatol. 149: 757-762.
121. Ulman C, Gezer S, Anal O, Ruhi Tore I, Kirca U. 1998. Arsenic in human and cow's milk: a reflection of environmental pollution. Water Air Soil Pollut. 101: 411-416.
122. Vahidnia A, van der Voet GB, de Wolff FA. 2007. Arsenic neurotoxicity - a review. Hum. Exp. Toxicol. 26: 823-832.
123. Vahter M. 1983. Metabolism of arsenic. In Fowler BA (ed.), Biological and Environmental Effects of Arsenic. New York: Elsevier Science; 171-198.
124. Valentine JL, Kang HK, Spivey G. 1979. Arsenic levels in human blood, urine and hair in response to exposure via drinking water. Environ. Res. 20: 24-32.
125. Valko M, Morris H, Cronin MT. 2005. Metals, toxicity and oxidative stress. Curr. Med. Chem. 12: 1161-1208.
126. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. 2006. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 160: 1-40.
127. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. 2007. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39: 44-84.
128. Vantroyen B, Heilier JF, Meulemans A, Michels A, Buchet JP, Vanderschueren S, Haufroid V, Sabbe M. 2004. Survival after a lethal dose of arsenic trioxide. J. Toxicol. Clin. Toxicol. 42: 889-895.
129. Vuyyuri SB, Ishaq M, Kuppala D, Grover P, Ahuja YR. 2006. Evaluation of micronucleus frequencies and DNA damage in glass workers exposed to arsenic. Environ. Mol. Mutagen. 47: 562-570.
130. Wall S. 1980. Survival and mortality pattern among Swedish smelter workers. Int. J. Epidemiol. 9: 73- 87.
131. Wang SL, Chiou JM, Chen CJ, Tseng CH, Chou WL, Wang CC, Wu TN, Chang LW. 2003. Prevalence of non-insulin-dependent diabetes mellitus and related vascular diseases in southwestern arseniasis-endemic and nonendemic areas in Taiwan. Environ. Health Perspect. 111: 155-159.
132. Wanibuchi H, Salim EI, Kinoshita A, Shen J, Wei M, Morimura K, Yoshida K, Kuroda K, Endo G, Fukushima S. 2004. Understanding arsenic carcinogenicity by the use of animal models. Toxicol. Appl. Pharmacol. 198: 366-376.
133. Wei M, Cohen SM, Cano M, Arnold LL. 2005. Effects of co-administration of antioxicants and arsenicals on the rat urinary bladder epithelium. Toxicol. Sci. 83: 237-245.
134. Welch K, Higgins I, Oh M, Burchfiel C. 1982. Arsenic exposure, smoking and respiratory cancer in copper smelter workers. Arch. Environ. Health 37: 325-335.
135. Woods JS, Fowler BA. 1978. Altered regulation of mammalian hepatic heme biosynthesis and urinary porphyrin excretion during prolonged exposure to sodium arsenate. Toxicol. Appl. Pharmacol. 43: 361-371.
136. Wyatt CJ, Fimbres C, Romo L, Méndez RO, Grijalva M. 1998. Incidence of heavy metal contamination in water supplies in Northern Mexico. Environ. Res. A76: 114-119.
137. Yamamoto S, Konishi Y, Matsuda T, Murai T, Shibata MA, Matsui-Yuasa I, Otani S, Kuroda K, Endo G, Fukushima S. 1995. Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens. Cancer Res. 55: 1271-1276.
138. Yamanaka K, Kato K, Mizoi M, An Y, Takabayashi F, Nakano M, Hoshino M, Okada S. 2004. The role of active arsenic species produced by metabolic reduction of dimethylarsinic acid in genotoxicity and tumorigenesis. Toxicol. Appl. Pharmacol. 198: 385-393.
139. Yang HT, Chou HJ, Han BC, Huang SY. 2007. Lifelong inorganic arsenic compounds consumption affected blood pressure in rats. Food Chem. Toxicol. 45: 2479-2487.